Indivior Files 2025 Annual Report to Security Holders
Ticker: INDV · Form: ARS · Filed: Mar 27, 2026 · CIK: 0001625297
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Indivior dropped its 2025 ARS on 3/27/26. Check financials.
AI Summary
Indivior Pharmaceuticals, Inc. filed an Annual Report to Security Holders (ARS) on March 27, 2026, for the period ending December 31, 2025. The filing, with SEC Accession No. 0001104659-26-035513, provides a comprehensive overview of the company's performance and financial standing for the fiscal year 2025. The report details the company's operations and outlook as a pharmaceutical preparations entity.
Why It Matters
This filing provides shareholders and potential investors with a detailed look at Indivior's financial health and strategic direction for the 2025 fiscal year, influencing investment decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing providing historical financial information and does not contain new material events or significant forward-looking statements that would indicate immediate risk.
Key Numbers
- 3742975 — ARS PDF Size (Size of the main ARS document file.)
- 5157157 — Submission Text File Size (Size of the complete submission text file.)
Key Players & Entities
- Indivior Pharmaceuticals, Inc. (company) — Filer
- 0001625297 (company) — CIK number for Indivior Pharmaceuticals, Inc.
- 0001104659-26-035513 (filing_id) — SEC Accession Number for the ARS filing
- 2026-03-27 (date) — Filing Date and Acceptance Date
- 2025-12-31 (date) — Period of Report
FAQ
What is the primary purpose of this ARS filing?
The primary purpose of this ARS filing is to provide an Annual Report to Security Holders for the period ending December 31, 2025.
When was this ARS filing accepted by the SEC?
This ARS filing was accepted by the SEC on March 27, 2026.
What is the CIK number for Indivior Pharmaceuticals, Inc.?
The CIK number for Indivior Pharmaceuticals, Inc. is 0001625297.
What is the fiscal year end for Indivior Pharmaceuticals, Inc.?
The fiscal year end for Indivior Pharmaceuticals, Inc. is December 31.
What is the SIC code for Indivior Pharmaceuticals, Inc.?
The SIC code for Indivior Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on March 27, 2026 regarding Indivior Pharmaceuticals, Inc. (INDV).